Luminal B (HER2-) breast cancer is defined as ER- or PR-positive and HER2-negative meeting with PR ≤ 20%, or ER- or PR-positive and HER2-negative with high Ki-67 index, which has worse prognoses. The locally specified Ki-67 cutoff value has remained elusive in China. 4940 patients with ER- or PR-positive and HER2-negative operable breast cancer were recruited. The novel findings was that luminal B (HER2-) tumors showed poor DFS regardless of Ki-67 cutoff values (14, 20 or 30%), and luminal B (HER2-) subtype(PR ≤ 20% and high Ki-67 index) tumors showed inferior OS, DMFS, and BCSS. With Ki-67 cutoff value of 20%, it was optimized to distinguish prognostic differences.
Building similarity graph...
Analyzing shared references across papers
Loading...
Xin Ye
Xiaoyun Zhou
Qi He
Cancer Investigation
Shanghai Jiao Tong University
Shanghai First Maternity and Infant Hospital
International Peace Maternity & Child Health Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Ye et al. (Mon,) studied this question.
www.synapsesocial.com/papers/6984345ff1d9ada3c1fb2788 — DOI: https://doi.org/10.1080/07357907.2026.2617267